These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10453390)

  • 1. How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?
    Jost S; Nolte CW; Sturm M; Hausleiter J; Hausmann D
    Int J Card Imaging; 1998 Dec; 14(6):357-72. PubMed ID: 10453390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of coronary vasomotor tone with intracoronary nitroglycerin.
    Jost S; Sturm M; Hausmann D; Lippolt P; Lichtlen PR
    Am J Cardiol; 1996 Jul; 78(1):120-3. PubMed ID: 8712104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducible uniform coronary vasomotor tone with nitrocompounds: prerequisite of quantitative coronary angiographic trials.
    Jost S; Rafflenbeul W; Reil GH; Gulba D; Knop I; Hecker H; Lichtlen PR
    Cathet Cardiovasc Diagn; 1990 Jul; 20(3):168-73. PubMed ID: 2114218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of variable vasomotor tone in studies with repeated quantitative coronary angiography.
    Jost S; Rafflenbeul W; Reil GH; Trappe HJ; Gulba D; Hecker H; Gerhardt U; Knop I
    Int J Card Imaging; 1990; 5(2-3):125-34. PubMed ID: 2121843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin.
    Schulz W; von Anderten W; Reiber JH; Bernauer R; Kaltenbach M; Kober G
    Z Kardiol; 1983; 72 Suppl 3():82-6. PubMed ID: 6421018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of normal and diseased epicardial coronary arteries to vasoactive drugs: quantitative arteriographic studies.
    Brown BG
    Am J Cardiol; 1985 Sep; 56(9):23E-29E. PubMed ID: 3901724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of calcium antagonists and nitroglycerin on large coronary artery diameter.
    Schwartz JS; Bache RJ
    Am Heart J; 1988 May; 115(5):964-9. PubMed ID: 3129925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.
    Serruys PW; Deckers JW; Luijten HE; Reiber JH; Tijssen JG; Chadha D; Hugenholtz PG
    Eur Heart J; 1987 Mar; 8(3):263-70. PubMed ID: 3582385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of coronary arteries to nitrates, the EDRF-donor SIN-1, and calcium antagonists.
    Schulz W; Kober G
    Basic Res Cardiol; 1991; 86 Suppl 2():233-41. PubMed ID: 1953615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery vasomotion and post-stenotic coronary artery blood flow after intracoronary lacidipine in patients with ischaemic heart disease: a pilot study.
    Vassanelli C; Menegatti G; Marini A; Beltrame F; Molinari J; Cemin R
    Drugs; 1999; 57 Suppl 1():19-26. PubMed ID: 10529079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease.
    Münzel T; Heitzer T; Kurz S; Harrison DG; Luhman C; Pape L; Olschewski M; Just H
    J Am Coll Cardiol; 1996 Feb; 27(2):297-303. PubMed ID: 8557897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem alone and combined with nitroglycerin: effect on normal and diseased human coronary arteries.
    Hess OM; Nonogi H; Bortone A; Gage JE; Grimm J; Krayenbuehl HP
    Eur Heart J; 1989 Nov; 10 Suppl F():142-6. PubMed ID: 2515968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroglycerin-induced coronary vasodilation is not enhanced in patients with impaired endothelium-dependent dilation.
    Anderson TJ; Meredith IT; Charbonneau F; Yeung AC; Dyce M; Selwyn AP; Ganz P
    J Am Coll Cardiol; 1996 Sep; 28(3):580-4. PubMed ID: 8772742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does intracoronary papaverine dilate epicardial coronary arteries? Implications for the assessment of coronary flow reserve.
    Zijlstra F; Reiber JH; Serruys PW
    Cathet Cardiovasc Diagn; 1988; 14(1):1-6. PubMed ID: 3349512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis.
    Schächinger V; Zeiher AM
    Circulation; 1995 Oct; 92(8):2087-94. PubMed ID: 7554186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of various doses of intracoronary diltiazem on coronary resistance vessels in humans.
    Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Ueda A; Kurisu S
    Jpn Circ J; 1995 Dec; 59(12):790-8. PubMed ID: 8788370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine.
    Schulz W; Kober G; Bernauer R; Kaltenbach M
    Am Heart J; 1985 Mar; 109(3 Pt 2):694-9. PubMed ID: 3838406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
    Schulz W; Wendt T; Scherer D; Kober G
    Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nitroglycerin and verapamil on coronary arterial distensibility as assessed by intravascular ultrasound.
    Akima T; Makkar R; Nishioka T; Dohad S; Iida K; Goland S; Kar S; Luo H; Siegel RJ
    J Invasive Cardiol; 2009 Apr; 21(4):162-7. PubMed ID: 19342754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.